Ocular Therapeutix CFO Smith departs | Personnel Moves – March 21, 2017

Ocular Therapeutix (NSDQ:OCUL) said yesterday that its chief financial officer, Bradford Smith, will resign from the company at the end of this month.

James Fortune, Ocular’s chief operating officer, will assume the roles of principal financial officer and principal accounting officer, according to a regulatory filing.

Get the full story at our sister site, Drug Delivery Business News.

The post Ocular Therapeutix CFO Smith departs | Personnel Moves – March 21, 2017 appeared first on MassDevice.

from MassDevice http://ift.tt/2mq5Ler